MOXR0916
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MOXR0916, covering 2019-05-31 to 2019-05-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy [Phase 2]